Zakażenie koronawirusem SARS-CoV-2 (COVID-19) a przewód pokarmowy Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
mar 31, 2020
Słowa kluczowe:
koronawirus, przewód pokarmowy, nieswoiste zapalenia jelit, profilaktyka w pracowni endoskopii
##plugins.themes.bootstrap3.article.main##
Abstrakt
Zakażenie koronawirusem SARS-CoV-2, obok manifestacji oddechowych, może powodować objawy ze strony przewodu pokarmowego. W transmisji infekcji dominuje droga kropelkowa, możliwe jest jednak również zakażenie drogą fekalno-oralną. W czasie pandemii konieczne jest przestrzeganie rygorystycznych zasad profilaktyki infekcji w gabinetach i na oddziałach gastroenterologii oraz w pracowniach endoskopii. Pacjenci z chorobami przewodu pokarmowego, szczególnie stosujący leki immunosupresyjne i immunomodulujące, powinni podlegać izolacji i zostać objęci odpowiednią opieką, w tym z zastosowaniem narzędzi telemedycyny.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Radwan, K. (2020). Zakażenie koronawirusem SARS-CoV-2 (COVID-19) a przewód pokarmowy . Medycyna Faktów , 13(1(46), 36-42. https://doi.org/10.24292/01.MF.0120.3
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Guan W.J., Ni Z.Y., Hu Y. et al.: Clinical characteristics of 2019 novel coronavirus infection in China. N. Engl. J. Med. 2020. https://doi.org/10.1056/NEJMoa2002032.
2. Chan J.F., Kok K.H., Zhu Z. et al.: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020; 9: 221-236.
3. Chan K.H., Poon L.L., Cheng V.C. et al.: Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 2004; 10: 294-99.
4. Mackay I.M., Arden K.E.: MERS coronavirus: diagnostics, epidemiology and transmission. Virol. J. 2015; 12: 222.
5. Wang D., Hu B., Hu C. et al.: Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585.
6. Gu J., Han B., Wang J.: COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.02.054.
7. Huang Ch., Wang Y., Li X. et al.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506.
8. Chen N., Zhou M., Dong X. et al.: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507-513.
9. Pan L., Mu M., Ren H.G. et al.: Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020; https://doi.org/10.14309/ajg.0000000000000620.
10. Yang X., Yu Y., Xu J. et al.: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020. https://doi.org/10.1016/S2213-2600(20)30079-5.
11. Lu R., Zhao X., Li J. et al.: Genomic characterisationand epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30251-8.
12. Wan Y., Shang J., Graham R. et al.: Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 2020. https://doi.org/10.1128/JVI.00127-20.
13. Huang Q., Herrmann A.: Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). Preprint bioRxiv 2020. https://doi.org/10.1101/2020.02.01.930537.
14. Yeo C., Kaushal S., Yeo D.: Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/S2468-1253(20)30048-0.
15. Holshue M.L., DeBolt C., Lindquist S. et al.: First Case of 2019 Novel Coronavirus in the United States. N. Engl. J. Med. 2020; 382(10): 929-936. https://doi.org/10.1056/NEJMoa2001191.
16. To K.K., Tsang O.T., Chik-Yan Yip C. et al.: Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. 2020. https://doi.org/10.1093/cid/ciaa149.
17. Song Y., Liu P., Shi X.L. et al.: SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020. https://doi.org/10.1136/gutjnl-2020-320891.
18. Guan G.W., Gao L., Wang J.W. et al.: [Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia]. Zhonghua Gan Zang Bing Za Zhi. 2020; 28: E002. https://doi.org/10.3760/cma.j.issn.1007-3418.2020.02.002.
19. Chai X.Q., Hu L.F., Zhang Y. et al.: Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. Preprint bioRxiv 2020. https://doi.org/10.1101/2020.02.03.931766.
20. Danese S., Cecconi M., Spinelli A.: Management of IBD during the COVID-19 outbreak: resetting clinical priorities. Nat. Rev. Gastroenterol. Hepatol. 2020. https://doi.org/10.1038/s41575-020-0294-8.
21. IOIBD: IOIBD Update on COVID19 for Patients with Crohn’s Disease and Ulcerative Colitis.
22. UEG: COVID-19 & Digestive Health. 27.03.2020.
23. Rejestr SECURE-IBD (Surveillance Epidemiology of Coronavirus Under Research Exclusion).
24. Mao R., Liang J., Shen J. et al.: Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/S2468-1253(20)30076-5.
25. Repici A., Maselli R., Colombo M. et al.: Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest. Endosc. 2020. https://doi.org/10.1016/j.gie.2020.03.019.
26. Marek T., Reguła J., Rydzewska G.: Wytyczne Polskiego Towarzystwa Gastroenterologii i konsultanta krajowego w dziedzinie gastroenterologii dotyczące wykonywania endoskopii przewodu pokarmowego w związku z epidemią COVID-19 (z dnia 16.03.2020).
2. Chan J.F., Kok K.H., Zhu Z. et al.: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020; 9: 221-236.
3. Chan K.H., Poon L.L., Cheng V.C. et al.: Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 2004; 10: 294-99.
4. Mackay I.M., Arden K.E.: MERS coronavirus: diagnostics, epidemiology and transmission. Virol. J. 2015; 12: 222.
5. Wang D., Hu B., Hu C. et al.: Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585.
6. Gu J., Han B., Wang J.: COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.02.054.
7. Huang Ch., Wang Y., Li X. et al.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506.
8. Chen N., Zhou M., Dong X. et al.: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507-513.
9. Pan L., Mu M., Ren H.G. et al.: Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020; https://doi.org/10.14309/ajg.0000000000000620.
10. Yang X., Yu Y., Xu J. et al.: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020. https://doi.org/10.1016/S2213-2600(20)30079-5.
11. Lu R., Zhao X., Li J. et al.: Genomic characterisationand epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30251-8.
12. Wan Y., Shang J., Graham R. et al.: Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 2020. https://doi.org/10.1128/JVI.00127-20.
13. Huang Q., Herrmann A.: Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). Preprint bioRxiv 2020. https://doi.org/10.1101/2020.02.01.930537.
14. Yeo C., Kaushal S., Yeo D.: Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/S2468-1253(20)30048-0.
15. Holshue M.L., DeBolt C., Lindquist S. et al.: First Case of 2019 Novel Coronavirus in the United States. N. Engl. J. Med. 2020; 382(10): 929-936. https://doi.org/10.1056/NEJMoa2001191.
16. To K.K., Tsang O.T., Chik-Yan Yip C. et al.: Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. 2020. https://doi.org/10.1093/cid/ciaa149.
17. Song Y., Liu P., Shi X.L. et al.: SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020. https://doi.org/10.1136/gutjnl-2020-320891.
18. Guan G.W., Gao L., Wang J.W. et al.: [Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia]. Zhonghua Gan Zang Bing Za Zhi. 2020; 28: E002. https://doi.org/10.3760/cma.j.issn.1007-3418.2020.02.002.
19. Chai X.Q., Hu L.F., Zhang Y. et al.: Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. Preprint bioRxiv 2020. https://doi.org/10.1101/2020.02.03.931766.
20. Danese S., Cecconi M., Spinelli A.: Management of IBD during the COVID-19 outbreak: resetting clinical priorities. Nat. Rev. Gastroenterol. Hepatol. 2020. https://doi.org/10.1038/s41575-020-0294-8.
21. IOIBD: IOIBD Update on COVID19 for Patients with Crohn’s Disease and Ulcerative Colitis.
22. UEG: COVID-19 & Digestive Health. 27.03.2020.
23. Rejestr SECURE-IBD (Surveillance Epidemiology of Coronavirus Under Research Exclusion).
24. Mao R., Liang J., Shen J. et al.: Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol. Hepatol. 2020. https://doi.org/10.1016/S2468-1253(20)30076-5.
25. Repici A., Maselli R., Colombo M. et al.: Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest. Endosc. 2020. https://doi.org/10.1016/j.gie.2020.03.019.
26. Marek T., Reguła J., Rydzewska G.: Wytyczne Polskiego Towarzystwa Gastroenterologii i konsultanta krajowego w dziedzinie gastroenterologii dotyczące wykonywania endoskopii przewodu pokarmowego w związku z epidemią COVID-19 (z dnia 16.03.2020).